Arvinas, Inc (ARVN) is a publicly traded Healthcare sector company. As of November 11, 2026, ARVN trades at $6.83 with a market cap of $442.68M and a P/E ratio of -1.13. ARVN moved -1.37% today. Year to date, ARVN is -39.80%; over the trailing twelve months it is -38.29%. Its 52-week range spans $5.90 to $14.51. Analyst consensus is buy with an average price target of $14.22. Rallies surfaces ARVN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ARVN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ARVN recently traded at $6.83. Market cap is $442.68M. P/E ratio is -1.13. Revenue is $78.50M.
| Metric | Value |
|---|---|
| Price | $6.83 |
| Market Cap | $442.68M |
| P/E Ratio | -1.13 |
| EPS | $-6.62 |
| Dividend Yield | 0.00% |
| 52-Week High | $14.51 |
| 52-Week Low | $5.90 |
| Volume | 488 |
| Avg Volume | 0 |
| Revenue (TTM) | $78.50M |
| Net Income | $-367.30M |
| Gross Margin | 0.00% |
12 analysts cover ARVN: 0 strong buy, 6 buy, 6 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $14.22.